SCHEMBL5929104

SCHEMBL5929104

CCc1cccc(CC)c1-c1ccccc1-c1ncsc1CN1CCCCC1c1ccc2c(c1)OCO2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CPT2 P23786 1/20 0.38
▸ CPT1A P50416 1/20 0.38
▸ POLB P06746 2/20 0.37
▸ KMT2A Q03164 4/20 0.36
▸ FAAH O00519 2/20 0.36
▸ BCHE P06276 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ TERT O14746 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ GPR35 Q9HC97 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ USP2 O75604 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5929101 0.79 TERT (0.42) CPT2CPT1APOLBKMT2AFAAH
SCHEMBL5929039 0.78 MAPT (0.40) KMT2AFAAHBCHEALDH1A1LMNA
SCHEMBL5928988 0.75 POLB (0.42) POLBKMT2ABCHEALDH1A1MEN1
SCHEMBL5929049 0.74 POLB (0.41) CPT2CPT1APOLBKMT2AFAAH
SCHEMBL5929070 0.74 KMT2A (0.41) CPT2CPT1APOLBKMT2AFAAH
SCHEMBL5929123 0.73 POLB (0.40) CPT2CPT1APOLBKMT2AFAAH
SCHEMBL5928927 0.72 KMT2A (0.41) POLBKMT2AFAAHALDH1A1MEN1
SCHEMBL5929306 0.71 C5AR1 (0.44) POLBKMT2AALDH1A1MEN1LMNA
SCHEMBL5929189 0.69 KMT2A (0.36) KMT2ABCHEALDH1A1LMNATERT
SCHEMBL5929107 0.68 KDM4E (0.39) POLBKMT2ABCHEALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators NEUROGEN CORPORATION (US) 2006-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154917-A1 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators C5AR1, C5AR2, C3AR1 CPT2 4682/4885CPT1A 4256/4885POLB 4751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback